Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Gastroenterology

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2001.04668.xPMID 11693333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test.

  2000influential reference
• Manual of Clinical Microbiology, 7th ed.

  2000cited by this paper
• Overuse of acid-suppressive therapy in hospitalized patients

  2000cited by this paper
• Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis

  2000cited by this paper
• Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis

  1999cited by this paper
• Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels.

  1999cited by this paper
• Omeprazole induces altered bile acid metabolism

  1998cited by this paper
• Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

  1998influential reference
• Effect of gastric acid suppressants on human gastric motility

  1998cited by this paper
• Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

  1998cited by this paper
• Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence.

  1998cited by this paper
• Long‐lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis

  1997cited by this paper
• Bacteriological method for detecting small intestinal hypomotility.

  1996cited by this paper
• Mucosal cytokine production in small-intestinal bacterial overgrowth.

  1996cited by this paper
• Small bowel bacterial overgrowth: epiphenomenon or bad actor in cirrhosis?

  1996cited by this paper
• Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited.

  1996cited by this paper
• Small bowel bacterial overgrowth in patients with alcoholic cirrhosis

  1995cited by this paper
• Fasting breath hydrogen concentrations in gastric and small-intestinal bacterial overgrowth.

  1995cited by this paper
• Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects.

  1994cited by this paper
• Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders.

  1993cited by this paper
• A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption.

  1993cited by this paper
• Comparison of three methods to obtain upper small bowel contents for culture.

  1993cited by this paper
• Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites.

  1993cited by this paper
• Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

  1992cited by this paper
• Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy.

  1992cited by this paper
• The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing.

  1990cited by this paper
• Breath hydrogen testing in bacterial overgrowth of the small intestine.

  1988cited by this paper
• Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors

  1988cited by this paper
• The effect of gastric secretion on orocoecal transit time measured with the hydrogen (H2) breath test.

  1987cited by this paper
• Tube for sampling of uncontaminated small-bowel juice.

  1983cited by this paper
• Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth.

  1982cited by this paper
• Infections of the Gastrointestinal Tract

  1980cited by this paper
• Breath-hydrogen test for small-intestinal bacterial colonisation.

  1976cited by this paper
• Manual of Clinical Microbiology

  1970cited by this paper

• Performance of fecal calprotectin and serum procalcitonin for the diagnosis of spontaneous bacterial peritonitis in patients with cirrhosis: A prospective diagnostic accuracy study.

  2026cites this paper
• Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Leberzirrhose-assoziierte Immundysfunktion (CAID)

  2026cites this paper
• Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis

  2025cites this paper
• Relación entre el sobrecrecimiento bacteriano intestinal y la calidad de vida en pacientes adultos con cirrosis hepática compensada

  2025cites this paper
• Small Intestinal Bacterial Overgrowth in Patients With Severe Alcoholic Hepatitis: Frequency and Predictors

  2025cites this paper
• The therapeutic potential of bacteriophage therapy in liver cirrhosis: a comprehensive review of current evidence

  2025cites this paper
• Hepatic encephalopathy: Part 1, a diagnostic approach

  2025cites this paper
• Rejuvenating bone marrow hematopoietic reserve prevents regeneration failure and hepatic decompensation in animal model of cirrhosis

  2024cites this paper
• Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases.

  2024cites this paper
• Infectious Complications of Portal Hypertension.

  2024cites this paper
• Infection, inflammation and hepatic encephalopathy from a clinical perspective

  2024cites this paper
• Research Progress of Malnutrition in Patients with Cirrhosis

  2023cites this paper
• Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites

  2023cites this paper
• Hepatic Encephalopathy in Acute-on-Chronic Liver Failure.

  2023cites this paper
• The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications

  2023cites this paper
• Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis

  2023cites this paper
• Hepatic Encephalopathy: Diagnostic Tools and Management Strategies.

  2023cites this paper
• The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.

  2022cites this paper
• Altered gut microbiota in patients with small intestinal bacterial overgrowth

  2022cites this paper
• The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression

  2022cites this paper
• Liver Steatosis: A Marker of Metabolic Risk in Children

  2022cites this paper
• Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association

  2022cites this paper
• Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?

  2022cites this paper
• Portopulmonary hypertension: Current developments and future perspectives

  2022cites this paper
• Pathophysiology and Management of Variceal Bleeding

  2021cites this paper
• An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis

  2021cites this paper
• Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases

  2021cites this paper
• Spontaneous Bacterial Peritonitis: Physiopathological Mechanism and Clinical Manifestations

  2021cites this paper
• A study to evaluate the hepatoprotective activity of prebiotics, probiotics, and synbiotic in CCl4 induced hepatotoxicity in rats

  2021cites this paper
• The microbiota in cirrhosis and its role in hepatic decompensation.

  2021cites this paper
• New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease

  2021cites this paper
• The Gut-Liver Axis in Cholestatic Liver Diseases

  2021cites this paper
• Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study

  2021cites this paper
• Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment

  2021cites this paper
• Predictors of Small Intestinal Bacterial Overgrowth in Symptomatic Patients Referred for Breath Testing

  2020cites this paper
• Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis

  2020cites this paper
• Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms

  2020cites this paper
• Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis

  2020cites this paper
• Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis.

  2020cites this paper
• Ginkgolide-A attenuates bacterial translocation through activating PXR and improving antimicrobial peptide Reg 3A in experimental cirrhosis.

  2020cites this paper
• Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

  2020cites this paper
• Nonpharmacologic Management of Hepatic Encephalopathy: An Update.

  2020cites this paper
• Small intestinal bacterial and fungal overgrowth

  2020cites this paper
• Bile microbiota: new insights into biliary complications in liver transplant recipients

  2020cites this paper
• Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis

  2020cites this paper
• Acid suppression therapy and its association with spontaneous bacterial peritonitis incidence: A systemic review and meta‐analysis

  2020cites this paper
• Chronic Liver Failure and Acute-on-Chronic Liver Failure

  2020cites this paper
• Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study

  2020cites this paper
• Spontaneous Bacterial Peritonitis and Secondary Bacterial Peritonitis—a Comprehensive Review

  2020cites this paper
• ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.

  2020cites this paper
• GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FB

  2020cites this paper
• Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology

  2020cites this paper
• IMMUNE MECHANISMS FOR THE DEVELOPMENT OF HEPATORENAL SYNDROME IN LIVER CIRRHOSIS

  2020cites this paper
• The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid

  2019cites this paper
• Intestinal Absorption of Bile Acids in Health and Disease.

  2019cites this paper
• Dynamic distribution of gallbladder microbiota in rabbit at different ages and health states

  2019cites this paper
• DISEASES OF THE LIVER AND INTESTINAL MICROBIOME

  2019cites this paper
• Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765

  2019cites this paper
• Management of Small Intestinal Bacterial Overgrowth in Adult Patients

  2019cites this paper
• Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies

  2019cites this paper
• Altered Microbiome in Patients With Cirrhosis and Complications

  2019cites this paper
• Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases.

  2019cites this paper
• Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.

  2019cites this paper
• Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art

  2019cites this paper
• Infections in cirrhotic patients

  2019cites this paper
• Microbiome in Liver Cirrhosis

  2019cites this paper
• Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions.

  2019cites this paper
• Nutrition in Cirrhosis

  2019cites this paper
• Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications

  2018cites this paper
• Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.

  2018cites this paper
• Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis

  2018cites this paper
• Plasma concentration of diamine oxidase (DAO) predicts 1-month mortality of acute-on-chronic hepatitis B liver failure.

  2018cites this paper
• Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

  2018cites this paper
• Update Review Article: Spontaneous Bacterial Peritonitis

  2018cites this paper
• Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis

  2018cites this paper
• Bacterial or fungal infections in patients with cirrhosis: epidemiology across the world, definition of sepsis and predictors of post discharge outcomes

  2018cites this paper
• PROTON PUMP INHIBITORS INCREASE THE OVERALL RISK OF DEVELOPING BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS.

  2018cites this paper
• Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial

  2018cites this paper
• SPONTANEOUS BACTERIAL PERITONITIS

  2018cites this paper
• Hydrogen Breath Tests

  2018cites this paper
• Malnutrition, frailty, sarcopenia, obesity—optimizing nutrition care in liver transplantation

  2018cites this paper
• Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study

  2017cites this paper
• Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review

  2017cites this paper
• Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence

  2017cites this paper
• Proton pump inhibitors in liver cirrhosis: a review of benefits and harms

  2017cites this paper
• The influence of bacterial infections on the course and outcome of patients with liver cirrhosis: Prophylaxis and treatment

  2017cites this paper
• Intestinal Graft Failure: Should We Perform the Allograft Enterectomy Before or With Retransplantation?

  2017cites this paper
• Spontaneous Bacterial Peritonitis (SBP)

  2017cites this paper
• Modulators of Enterococcus faecalis Cell Envelope Integrity and Antimicrobial Resistance Influence Stable Colonization of the Mammalian Gastrointestinal Tract

  2017cites this paper
• Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis

  2017cites this paper
• Malnutrition and Liver Disease

  2017cites this paper
• Gut microbiome and liver disease.

  2017cites this paper
• Is periodontitis a risk factor for infections in cirrhotic patients?

  2017cites this paper
• Risks of PEG tube placement in patients with cirrhosis-associated ascites

  2017cites this paper
• Gut Microbiota and Complications of Liver Disease.

  2017cites this paper
• Acid-Suppressive Therapy and Risk of Infections: Pros and Cons

  2017cites this paper
• In Vitro Antibacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureus

  2017cites this paper
• Prevalence and clinical significance of small intestinal bacterial overgrowth in patients with chronic liver disease

  2017cites this paper
• Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats

  2017cites this paper